NZ264479A - Use of imidazopyridazine or triazolopyridazine derivatives as eosinophil chemotaxis inhibitors - Google Patents
Use of imidazopyridazine or triazolopyridazine derivatives as eosinophil chemotaxis inhibitorsInfo
- Publication number
- NZ264479A NZ264479A NZ264479A NZ26447994A NZ264479A NZ 264479 A NZ264479 A NZ 264479A NZ 264479 A NZ264479 A NZ 264479A NZ 26447994 A NZ26447994 A NZ 26447994A NZ 264479 A NZ264479 A NZ 264479A
- Authority
- NZ
- New Zealand
- Prior art keywords
- imidazopyridazine
- eosinophil chemotaxis
- triazolopyridazine derivatives
- chemotaxis inhibitors
- inhibitors
- Prior art date
Links
- CBHTTYDJRXOHHL-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridazine Chemical class N1=NC=CC2=C1N=NN2 CBHTTYDJRXOHHL-UHFFFAOYSA-N 0.000 title 1
- MJQSRSOTRPMVKB-UHFFFAOYSA-N 5h-imidazo[4,5-c]pyridazine Chemical compound C1=NNC2=NC=NC2=C1 MJQSRSOTRPMVKB-UHFFFAOYSA-N 0.000 title 1
- 229940105129 Chemotaxis inhibitor Drugs 0.000 title 1
- 239000002819 chemotaxis inhibitor Substances 0.000 title 1
- 230000013764 eosinophil chemotaxis Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23476493 | 1993-09-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ264479A true NZ264479A (en) | 1999-05-28 |
Family
ID=16975996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ264479A NZ264479A (en) | 1993-09-21 | 1994-09-19 | Use of imidazopyridazine or triazolopyridazine derivatives as eosinophil chemotaxis inhibitors |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5922712A (en:Method) |
| EP (2) | EP0865790A3 (en:Method) |
| KR (1) | KR100280240B1 (en:Method) |
| CN (1) | CN1109885A (en:Method) |
| AU (1) | AU686210B2 (en:Method) |
| CA (1) | CA2132489A1 (en:Method) |
| FI (1) | FI944354A0 (en:Method) |
| NO (1) | NO307547B1 (en:Method) |
| NZ (1) | NZ264479A (en:Method) |
| TW (1) | TW304878B (en:Method) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU695377B2 (en) * | 1994-09-16 | 1998-08-13 | Takeda Chemical Industries Ltd. | Triazolopyridazines process and intermediates for their preparation and their use as medicaments |
| US6248740B1 (en) | 1997-04-25 | 2001-06-19 | Takeda Chemical Industries, Ltd. | Condensed pyridazine derivatives, their production and use |
| AU3274199A (en) * | 1998-03-04 | 1999-09-20 | Takeda Chemical Industries Ltd. | Triazolo-pyridazine derivatives for the treatment of chronic obstructive pulmonary diseases |
| EP1120418A4 (en) | 1998-10-06 | 2005-01-26 | CONDENSED PYRIDAZINE COMPOUNDS, METHOD FOR PREPARING SAME AND USE THEREOF | |
| AU6227399A (en) | 1998-10-21 | 2000-05-08 | Takeda Chemical Industries Ltd. | Fused pyridazine derivatives, process for the preparation of the same and uses thereof |
| WO2001021177A1 (fr) * | 1999-09-20 | 2001-03-29 | Takeda Chemical Industries, Ltd. | Inhibiteurs d'expression de chemokine/cytokine |
| AU1054301A (en) * | 1999-11-11 | 2001-06-06 | Takeda Chemical Industries Ltd. | Nasal drops containing fused pyridazine derivatives |
| CA2634721C (en) | 2005-12-21 | 2014-06-17 | Janssen Pharmaceutica N.V. | Triazolopyridazines as tyrosine kinase modulators |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3446812A1 (de) * | 1984-12-21 | 1986-06-26 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue imidazoderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| GB8826205D0 (en) * | 1988-11-09 | 1988-12-14 | Wellcome Found | Heterocyclic compounds |
| PH27291A (en) * | 1989-01-31 | 1993-05-04 | Takeda Chemical Industries Ltd | Imidazolpyrimidazines their production and use |
| EP0440119A1 (en) * | 1990-01-31 | 1991-08-07 | Takeda Chemical Industries, Ltd. | Imidazopyridazine compounds, their production and use |
| US5011835A (en) * | 1990-02-07 | 1991-04-30 | Merrell Dow Pharmaceuticals Inc. | Substituted triazolopyridazines, pharmaceutical compositions and use |
| DE69106902T2 (de) * | 1990-03-01 | 1995-07-06 | Takeda Chemical Industries Ltd | Imidazopyridazine, ihre Herstellung und Verwendung. |
| DE4007373A1 (de) * | 1990-03-08 | 1991-09-12 | Precitronic | Pyrotechnische vorrichtung |
| EP0561973A1 (en) * | 1990-12-14 | 1993-09-29 | Merrell Dow Pharmaceuticals Inc. | Antiallergic compounds |
| TW211013B (en:Method) * | 1991-12-27 | 1993-08-11 | Takeda Pharm Industry Co Ltd | |
| LT3200B (en) * | 1992-03-18 | 1995-03-27 | Takeda Chemical Industries Ltd | Triazolopyridazine methodfor production thereof and use |
| ATE174916T1 (de) * | 1992-03-18 | 1999-01-15 | Takeda Chemical Industries Ltd | Imidazopyridazine als antiasthmatika |
-
1994
- 1994-09-09 TW TW083108317A patent/TW304878B/zh active
- 1994-09-12 AU AU72926/94A patent/AU686210B2/en not_active Ceased
- 1994-09-17 EP EP98110050A patent/EP0865790A3/en not_active Withdrawn
- 1994-09-17 KR KR1019940023814A patent/KR100280240B1/ko not_active Expired - Fee Related
- 1994-09-17 EP EP94114661A patent/EP0648491A3/en not_active Withdrawn
- 1994-09-19 NZ NZ264479A patent/NZ264479A/xx unknown
- 1994-09-20 CN CN94115326A patent/CN1109885A/zh active Pending
- 1994-09-20 CA CA002132489A patent/CA2132489A1/en not_active Abandoned
- 1994-09-20 NO NO943494A patent/NO307547B1/no not_active IP Right Cessation
- 1994-09-20 FI FI944354A patent/FI944354A0/fi unknown
-
1998
- 1998-05-01 US US09/070,928 patent/US5922712A/en not_active Expired - Fee Related
-
1999
- 1999-02-16 US US09/250,392 patent/US5945419A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0648491A3 (en) | 1995-07-19 |
| CA2132489A1 (en) | 1995-03-22 |
| EP0865790A3 (en) | 1999-03-10 |
| EP0648491A2 (en) | 1995-04-19 |
| NO307547B1 (no) | 2000-04-25 |
| US5922712A (en) | 1999-07-13 |
| TW304878B (en:Method) | 1997-05-11 |
| CN1109885A (zh) | 1995-10-11 |
| FI944354A0 (fi) | 1994-09-20 |
| NO943494L (no) | 1995-03-22 |
| US5945419A (en) | 1999-08-31 |
| AU686210B2 (en) | 1998-02-05 |
| NO943494D0 (no) | 1994-09-20 |
| AU7292694A (en) | 1995-04-06 |
| EP0865790A2 (en) | 1998-09-23 |
| KR100280240B1 (ko) | 2001-02-01 |
| KR950007851A (ko) | 1995-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI945363L (fi) | Uusia merkaptoasetyyliamidopyridatso (1,2)pyridatsiini-, pyratsolo(1,2)pyridatsiini-, pyridatso (1,2-a)(1,2)diatsepiini- ja pyratsolo(1,2-a)(1,2)diatsepiinijohdannaisia, jotka ovat käyttökelpoisia enkefalisaasin ja ACE:n estäjinä | |
| PL313619A1 (en) | Derivatives of piperydine | |
| AU3612895A (en) | Purine and guanine compounds as inhibitors of pnp | |
| HU9401437D0 (en) | Use of multi-staged betex and process for meting the multi-steged betex | |
| IL106712A0 (en) | Handle for defence and as carrier | |
| PL306127A1 (en) | Derivatives of epi-epibathydine | |
| PL322452A1 (en) | 6-arylpyrasole [3,4-d]pyrimidin-4-ones, preparations containing such compounds and methods of mking use of them | |
| ZA941926B (en) | Heterocyclic compounds their preparation and use | |
| NZ264479A (en) | Use of imidazopyridazine or triazolopyridazine derivatives as eosinophil chemotaxis inhibitors | |
| PL314008A1 (en) | Derivatives of flavine as antiviral agents | |
| ZA945689B (en) | Pyrimido pyrimidine compounds | |
| GB9313188D0 (en) | Medical use of enzymes | |
| PL306204A1 (en) | Novel derivatives of imidazopyrimidine | |
| GR3023491T3 (en) | Use of ferrocene | |
| ZA964932B (en) | New use of pyrrole derivatives | |
| AU1292995A (en) | Bis-oxazolidine compounds and their use | |
| ZA944932B (en) | Use of phenalkylamines | |
| ZA933260B (en) | Novel mercaptoacetylamido pyridazo(1,2)pyridazine, pyrazolo(1,2)pyridazine, pyridazo(1,2-a)(1,2)diazepine and pyrazolo(1,2-a)(1,2)diazepine derivatives useful as inhibitors of enkephalinase and ACE | |
| GB9303518D0 (en) | Combinations of retroviral inhibitors | |
| CA72766S (en) | Set of handles | |
| KR0109170Y1 (en) | Details of tables | |
| GB9321303D0 (en) | Use of an enzyme | |
| AU7843198A (en) | Pyrazolopyrimidines having CRF antagonist activity | |
| AU7070494A (en) | Bicyclic ether derivatives and their use as 5-lipoxygenase inhibitors | |
| GB9313512D0 (en) | Derivatives of 1-cyclohexyl-piperidine |